Scandinavian Medical Solutions AS Capital Reinvestment Ratio

Latest as of September 2024: 0.85x

Scandinavian Medical Solutions AS capital reinvestment ratio. Scandinavian Medical Solutions AS (SMSMED) has a Capital Reinvestment Ratio of 0.85x as of September 2024, meaning it reinvests 1% of its operating cash flow (Dkr17.86 Million) in capital expenditures (Dkr15.13 Million). See cash generation quality of Scandinavian Medical Solutions AS to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.85x
Capex / Operating Cash Flow

Operating Cash Flow

Dkr17.86 Million
DKK

Capital Expenditures

Dkr15.13 Million
DKK

Data as of

Sep 2024
Most recent filing

Capital Reinvestment Ratio of Scandinavian Medical Solutions AS (2020–2024)

Capital reinvestment ratio of Scandinavian Medical Solutions AS from 2020 to 2024. This chart tracks Scandinavian Medical Solutions AS's Capital Reinvestment Ratio across 3 annual periods. See financial flexibility index of Scandinavian Medical Solutions AS to measure the company's free cash flow as a share of total liabilities.

Scandinavian Medical Solutions AS Capital Reinvestment Ratio by Year (2020–2024)

Scandinavian Medical Solutions AS capital reinvestment ratio by year from 2020 to 2024. For the full cash flow conversion analysis, see Scandinavian Medical Solutions AS cash flow conversion.

Year Reinvestment Ratio Operating CF (DKK) Capital Expenditures YoY Change
2024 5.44x Dkr3.39 Million Dkr18.47 Million ▲ +438250430.7%
2021 0.00x Dkr4.02 Million Dkr5.00 ▼ -100.0%
2020 1.47x Dkr9.38 Million Dkr13.76 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow